BI 765845

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 765845, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack [Phase 2]